| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 10/26/2006 | US20060242721 Gene families associated with liver cancer |
| 10/26/2006 | US20060242720 Inducible site-directed mutagenesis through conditional gene rescue |
| 10/26/2006 | US20060242719 Nucleotide sequences of shrimp beta-actin and actin promoters and their use in gentic transformation technology |
| 10/26/2006 | US20060242718 SOCS-box containing peptides |
| 10/26/2006 | US20060242717 Expression systems |
| 10/26/2006 | US20060242716 Disease model animal carrying foreign ppar alpha gene transferred thereinto and use thereof |
| 10/26/2006 | US20060241978 Electronic clinical chart system |
| 10/26/2006 | US20060241291 Purified antibody, monoclonal antibody, or polyclonal antibody that binds to DES protein of Mycobacterium tuberculosis; medical diagnosis |
| 10/26/2006 | US20060241076 Modified oligoribonucleotide analogs with enhanced immunostimulatory activity |
| 10/26/2006 | US20060241072 Oligomeric compounds for use in gene modulation |
| 10/26/2006 | US20060241070 Antisense oligonucleotides directed to ribonucleotide reductase r2 and uses thereof in the treament of cancer |
| 10/26/2006 | US20060241069 Treatment of hyperproliferative disease |
| 10/26/2006 | US20060241068 Cardiac failure, cardiomegaly, myocarditis, cardiomyopathy, arteriosclerosis, arteriosclerosis obliterans, or ischemic heart disease |
| 10/26/2006 | US20060241066 Decoy composition for treating and preventing inflammatory disease |
| 10/26/2006 | US20060241044 Encoding delta-endotoxins having pesticidal activity against insect pests such as Lepidoptera |
| 10/26/2006 | US20060241043 Bacillus Cry9 family members |
| 10/26/2006 | US20060241041 Fvii or fviia gla domain variants |
| 10/26/2006 | US20060241034 Means for preventing and treating cellular death and their biological applications |
| 10/26/2006 | US20060241033 Markers for pre-cancer and cancer calls and the method to interfere with cell proliferation therein |
| 10/26/2006 | US20060240556 Use of RNA interference for the creation of lineage specific ES and other undifferentiated cells and production of differentiated cells in vitro by co-culture |
| 10/26/2006 | US20060240553 Cultures of human CNS neural stem cells |
| 10/26/2006 | US20060240539 A Streptococcus thermophilus deposited on 26th Feb. 2003 at the Collection Nationale de Cultures de Microorganismes under number I-2980; extends shelf-life of dairy product; fermentation |
| 10/26/2006 | US20060240537 Isolated nucleic acid sequence encoding plant acid phosphatase |
| 10/26/2006 | US20060240534 Process for producing scyllo-inositol |
| 10/26/2006 | US20060240533 Assembly for the stabilisation of vertebral bodies of the spine |
| 10/26/2006 | US20060240532 Amplification, translation, transcription |
| 10/26/2006 | US20060240531 Processes for producing isomaltose and isomaltitol and use thereof |
| 10/26/2006 | US20060240530 cDNA of a severe acute respiratory syndrome (SARS) coronavirus, recombinant SARS coronavirus vectors, and SARS coronavirus replicon particles |
| 10/26/2006 | US20060240528 Polyketides and their synthesis |
| 10/26/2006 | US20060240526 Amino acid substitution in position 36; brain bleeding, hemorrhage, trauma or injury; genetic engineering and expression; biodrugs, anticoagulants |
| 10/26/2006 | US20060240525 Factor VII or VIIa - Like Molecules |
| 10/26/2006 | US20060240524 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia |
| 10/26/2006 | US20060240522 Process for bacterial production of polypeptides |
| 10/26/2006 | US20060240521 DNA sequences for regulating transcription |
| 10/26/2006 | US20060240520 monitoring the efficacy of a BAFF-R (a B-cell activating factor belonging to the Tumor Necrosis Factor family) antagonist in the treatment of a disease or disorder associated with aberrant levels of B-cells or B-cell activity |
| 10/26/2006 | US20060240519 Novel receptor nucleic acids and polypeptides |
| 10/26/2006 | US20060240518 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells |
| 10/26/2006 | US20060240517 Novel receptor nucleic acids and polypeptides |
| 10/26/2006 | US20060240513 Cultures of E1-immortalized cells and processes for culturing the same to increase product yields therefrom |
| 10/26/2006 | US20060240512 Inducing oocyte activation by administering sperm perinuclear theca protein 34; interacts with tyrosine kinase; enhancing fertility; treating or diagnosing diminished fertility and abnormal spermiogenesis, providing contraception; identifying contraceptive and fertility-enhancing agents |
| 10/26/2006 | US20060240510 Method for designing peptides |
| 10/26/2006 | US20060240509 Myrothecium sp transformation and expression system |
| 10/26/2006 | US20060240508 By culturing yeast organisms that have an increased Delta 8-, Delta 7-, Delta 24-, Delta 5-isomerase and HMG-CoA-reductase activity |
| 10/26/2006 | US20060240505 Identification of Targets of Antimicrobial Compounds |
| 10/26/2006 | US20060240502 GTP cyclohydrolase II as a target for fungicides |
| 10/26/2006 | US20060240491 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection |
| 10/26/2006 | US20060240483 Inducing signalosome formation in cells, lysing and incubating the cell lysate on a solid phase coated with antibody capable of capturing the receptor within the signalosome, separating solid phase from the cell lysate, and detecting and measuring the amount of the protein bound to the solid phase |
| 10/26/2006 | US20060240472 Pigment protein |
| 10/26/2006 | US20060240471 Genetic test for the identification of carriers of complex vertebral malformations in cattle |
| 10/26/2006 | US20060240469 Method for generating transcriptionally active DNA fragments |
| 10/26/2006 | US20060240468 Method of reverse transcription |
| 10/26/2006 | US20060240465 CNG2B: a novel human cyclic nucleotide-gated ion channel |
| 10/26/2006 | US20060240450 Genetic analysis for stratification of cancer risk |
| 10/26/2006 | US20060240448 Cell concentration and lysate clearance using paramagnetic particles |
| 10/26/2006 | US20060240446 Novel human cytomegalovirus DNA sequences |
| 10/26/2006 | US20060240440 primer amplification |
| 10/26/2006 | US20060240432 Transmembrane serine protease probes for use as evaluative tool in detection of nervous system stem cells and treatment of neurodegenerative diseases; regenerative medicine; tissue engineering |
| 10/26/2006 | US20060240429 Method of screening compound inhibiting enzymatic activity of gwt1 gene product |
| 10/26/2006 | US20060240428 Method of identifying disease-sensitivity gene and program and system to be used therefor |
| 10/26/2006 | US20060240424 Regulation of human p2y15 g protein-coupled receptor |
| 10/26/2006 | US20060240423 Isolation and cloning of dna from uncultivated organisms |
| 10/26/2006 | US20060240420 Nucleic acid amplification method |
| 10/26/2006 | US20060240417 Agent controlling the apoptosis induction by p73 |
| 10/26/2006 | US20060240414 Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
| 10/26/2006 | US20060240404 Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents |
| 10/26/2006 | US20060240114 Drug for treating hemophilia and method of treating hemophilia using the same |
| 10/26/2006 | US20060240112 removal of DNA associated with riboflavin (vitamin B2) crystals; fermentation; precipitation; crystallization |
| 10/26/2006 | US20060240093 silencing gene expression by delivering nucleic acid-lipid particles comprising a siRNA molecule to a cell; hepatitis |
| 10/26/2006 | US20060240088 Caged ligands and uses thereof |
| 10/26/2006 | US20060240044 Streptococcal superantigens spe-l and spe-m |
| 10/26/2006 | US20060240042 genetic vaccines; Gag, Pol, Pro, Tat, Nef, Rev, Vif, Vpr or Env antigens |
| 10/26/2006 | US20060240041 PRRSV Vaccines |
| 10/26/2006 | US20060240040 Optimized expression of hpv 45 l1 in yeast |
| 10/26/2006 | US20060240036 I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis |
| 10/26/2006 | US20060240035 Vmp-like sequences of pathogenic borrelia species and strains |
| 10/26/2006 | US20060240034 Vaccine against infections caused by oncoviruses such as the feline leucosis virus of cats |
| 10/26/2006 | US20060240029 Chlamydia pneumoniae antigens |
| 10/26/2006 | US20060240022 Factor involved in metastasis and uses thereof |
| 10/26/2006 | US20060240020 Inhibition of complement activation |
| 10/26/2006 | US20060240018 Artificial antibody polypeptides |
| 10/26/2006 | US20060240015 Recombinant antibody against human insulin-like growth factor |
| 10/26/2006 | US20060240012 For treating inflammation and immunopathy; rheumatoid arthritis |
| 10/26/2006 | US20060240010 Methods of modulating CD200 receptors |
| 10/26/2006 | US20060240004 Methods for treating tweak-related conditions |
| 10/26/2006 | US20060240003 Humanised antibodies to the epidermal growth factor receptor |
| 10/26/2006 | US20060239996 ANTIBODIES SPECIFIC FOR UNGULATE PrP |
| 10/26/2006 | US20060239993 Containing a mutant angiotensin-converting enzyme that releases glycosylphosphatidylinositol-anchored protein from cell surfaces; for treating a prion-related disease, a bacterial infectious disease or male infertility due to sperm-egg binding insufficiency |
| 10/26/2006 | US20060239991 polypeptide has the biological activity of methionyl tRNA synthetase; for the protection against bacterial infections |
| 10/26/2006 | US20060239989 Stable and which can be obtained in a large quantity, with a high level of purity and of activity |
| 10/26/2006 | US20060239985 Method of preparing cell for transplantation |
| 10/26/2006 | US20060239984 Promoter to il-18bp, its preparation and use |
| 10/26/2006 | US20060239980 Cartilage-derived stem cells and applications thereof |
| 10/26/2006 | US20060239978 Cellular expression of 65B13 in the neurons can be used as an index to select cells that are suitable in terms of their safety, survival rate, and network formation ability, for transplant therapy of neurodegenerative diseases such as Parkinson's disease |
| 10/26/2006 | US20060239976 75K RNA regulated transcription |
| 10/26/2006 | US20060239974 Enhancing cell migration by increasing telomerase activity |
| 10/26/2006 | US20060239973 Methods and compositions for the treatment of ocular diseases |
| 10/26/2006 | US20060239972 Adiponectin gene therapy |
| 10/26/2006 | US20060239971 Vectors for regulating gene expression |
| 10/26/2006 | US20060239970 Herpesvirus amplicon particles |
| 10/26/2006 | US20060239969 Isolated nucleic acid molecule; enhancing immunity to the protein product expressed by the HER2/neu tumor-associated antigen |